Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Mid Cap | Pharmaceuticals & Drugs
1458.45
2.20 (0.15%)
< Home < Back

CARE reaffirms rating of Cipla’s bank facilities

Date: 01-03-2013

Credit rating agency, CARE has reaffirmed ‘AAA’ rating to Cipla’s long-term bank facilities worth Rs 72.38 crore which was enhanced from 68.60 crore and ‘A1+’ rating to company’s short-term bank facilities  worth Rs 1,723.50 crore.

The company has received the said rating on the back of its leading market position in respiratory segment, stable business performance, continuing strong financial profile characterized by low gearing levels and a healthy liquidity position.

Cipla focuses on development of new formulations and has a wide range of pharmaceutical products. It offers prescription drugs, bulk drugs, animal products and pesticides. It also offers a wide range of food and beverages, baked foods, oral hygiene products, detergents, room fresheners and personal care products.